Milena Pavlova, MD, neurologist, and medical director of the sleep testing center at Brigham and Women’s Faulkner hospital, talks about the importance of treating underlying sleep disorders in patients with seizures, especially within a value-based care (VBC) model.
Poor sleep usually worsens seizures, says Milena Pavlova, MD, neurologist, and medical director of the sleep testing center at Brigham and Women’s Faulkner hospital.
Transcript
What role does value-based care play in patients with epilepsy who have sleep disorders?
When it comes to value-based care, it really depends on how the measurement is done. Whether we are talking about value in the immediate setting, or value in the longer-term health of the patient. I would say the treatment of sleep disorders is important, both in the short-term and in the long-term setting. In terms of the short-term setting, poor sleep is now a very well recognized risk factor for car accidents. So, from that perspective, it's a big risk, although I'm not sure how well this is actually reflected into the models of pay for services. But in terms of the overall health, there is currently a massive amount of evidence that various sleep disorders tend to be culprits for worsening health, and what I'll be talking about is going to be the role of sleep apnea for patients with epilepsy. Sleep apnea specifically is a well-recognized risk factor for myocardial infarction. It's a risk factor for stroke, as you know, stroke leads to disability and a lot of health utilization. Various sleep disorders have been implicated in the pathogenesis of worsening of various disorders of cognition, they have a role in dementia, they have a role in mood disorders, and also epilepsy, and I'm going to be talking about this a little bit more in detail because poor sleep tends to worsen seizures, that's the bottom line. So, in a value-based model, the frequency of seizures should be balanced with treatment of any underlying sleep disorders.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More